[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biolife Solutions (BLFS)

Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,009,470
  • Shares Outstanding, K 48,300
  • Annual Sales, $ 96,210 K
  • Annual Income, $ -4,600 K
  • EBIT $ -16 M
  • EBITDA $ -12 M
  • 60-Month Beta 2.00
  • Price/Sales 10.75
  • Price/Cash Flow 93.50
  • Price/Book 2.77

Options Overview Details

View History
  • Implied Volatility 100.24% (+7.82%)
  • Historical Volatility 43.15%
  • IV Percentile 60%
  • IV Rank 35.43%
  • IV High 188.31% on 03/26/26
  • IV Low 51.91% on 08/18/25
  • Expected Move (DTE 16) 0.00 (0.00%)
  • Put/Call Vol Ratio 1.00
  • Today's Volume 4
  • Volume Avg (30-Day) 5
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 51
  • Open Int (30-Day) 131
  • Expected Range 19.92 to 19.92

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.00
  • Number of Estimates 2
  • High Estimate $0.02
  • Low Estimate $-0.01
  • Prior Year $0.04
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.89 +10.34%
on 03/30/26
23.18 -14.84%
on 04/22/26
+1.15 (+6.19%)
since 03/27/26
3-Month
17.86 +10.53%
on 03/13/26
25.25 -21.82%
on 02/27/26
-2.84 (-12.58%)
since 01/29/26
52-Week
17.86 +10.53%
on 03/13/26
29.62 -33.36%
on 10/24/25
-4.97 (-20.11%)
since 04/29/25

Most Recent Stories

More News
BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026

BOTHELL, Wash. , April 23, 2026 /PRNewswire/ -- BioLife Solutions, Inc.  (NASDAQ: BLFS ), a leading developer and supplier of bioproduction products and services for the cell and gene therapy...

BLFS : 19.78 (-5.36%)
BioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing Operations

Fourth quarter 2025  revenue from continuing operations of $24.8 million, up 20% year-over-year; Full year   2025 revenue of $96.2 million, up 29% year-over-year

BLFS : 19.78 (-5.36%)
BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026

BOTHELL, Wash. , Feb. 17, 2026 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy...

BLFS : 19.78 (-5.36%)
BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market

BOTHELL, Wash. , Feb. 12, 2026 /PRNewswire/ --  BioLife Solutions, Inc. (NASDAQ: BLFS ), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy...

BLFS : 19.78 (-5.36%)
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing Operations

Fourth quarter unaudited revenue from continuing operations of $24.8 million increased 20% from the prior year fourth quarter

BLFS : 19.78 (-5.36%)
BioLife Solutions Unveils the Aby J. Mathew Center for Biopreservation Excellence

New conference and laboratory facility to showcase the company's product portfolio and serve as a research and training hub to advance biopreservation and cell processing innovation

BLFS : 19.78 (-5.36%)
BioLife Solutions to Participate in Upcoming Investor Conferences in November and December 2025

BOTHELL, Wash. , Nov. 17, 2025 /PRNewswire/ -- BioLife Solutions , Inc.  (NASDAQ: BLFS ), a leading developer and supplier of bioproduction products and services for the...

BLFS : 19.78 (-5.36%)
BioLife Solutions Reports Third Quarter 2025 Financial Results

Cell Processing revenue of $25.4 million, up 33% over Q3 2024

BLFS : 19.78 (-5.36%)
BioLife Solutions to Report Third Quarter 2025 Financial Results and Business Update on November 6, 2025

BOTHELL, Wash. , Oct. 23, 2025 /PRNewswire/ --  BioLife Solutions, Inc . (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy...

BLFS : 19.78 (-5.36%)
BioLife Solutions (BLFS) Gets a Buy from Northland Securities

Northland Securities analyst Carl Byrnes maintained a Buy rating on BioLife Solutions today and set a price target of $31.00. The company’s shares closed yesterday at $26.30.Elevate Your Investing Strategy:...

BLFS : 19.78 (-5.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of...

See More

Key Turning Points

3rd Resistance Point 21.99
2nd Resistance Point 21.71
1st Resistance Point 21.30
Last Price 19.78
1st Support Level 20.61
2nd Support Level 20.33
3rd Support Level 19.92

See More

52-Week High 29.62
Fibonacci 61.8% 25.13
Fibonacci 50% 23.74
Fibonacci 38.2% 22.35
Last Price 19.78
52-Week Low 17.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.